Socioeconomic status in HCV infected patients - Risk and prognosis

Clinical Epidemiology

Volumn 5, Issue 1, 2013, Pages 163-172

  Omland, Lars Haukali ^a   Osler, Merete ^b   Jepsen, Peter ^c   Krarup, Henrik ^d   Weis, Nina ^e   Christensen, Peer Brehm ^f   Roed, Casper ^a   Sørensen, Henrik Toft ^c   Obel, Niels ^a  

^a Rigshospitalet   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e HVIDOVRE HOSPITAL   (Denmark)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Prognosis; Risk factor; Socioeconomic status; Survival

Indexed keywords

ADULT; ARTICLE; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; DISABLED PERSON; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MORTALITY; PENSIONER; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; SUBSTANCE ABUSE; SURVIVAL RATE; UNEMPLOYMENT;

EID: 84878501704     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S43926     Document Type: Article

References (60)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244:359-362.
2. World Health Organization. Hepatitis C - global prevalence (update). Wkly Epidemiol Rec. 1999;74:425-427.
3. Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis. 2007;39:2-17.
4. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet. 2006;368:938-945.
5. Duberg AS, Nordstrom M, Torner A, et al. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology. 2005;41:652-659.
6. Duberg AS, Pettersson H, Aleman S, et al. The burden of hepatitis C in Sweden: a national study of inpatient care. J Viral Hepat. 2011;18: 106-118.
7. Neal KR, Ramsay S, Thomson BJ, Irving WL. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study. Gut. 2007;56:1098-1104.
8. Omland LH, Krarup H, Jepsen P, et al; DANVIR Cohort Study. Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study. J Hepatol. 2010;53:36-42.
9. Omland LH, Jepsen P, Krarup H, et al; DANVIR Cohort Study. Increased mortality among persons infected with hepatitis C virus. Clin Gastroenterol Hepatol. 2011;9:71-78.
10. Omland LH, Jepsen P, Krarup H, et al; DANVIR Cohort Study. Liver cancer and non-hodgkin lymphoma in hepatitis C virus-infected patients: results from the DANVIR cohort study. Int J Cancer. 2012; 130(5):2310-2317.
11. Lee MH, Yang HI, Lu SN, et al; R.E.V.E.A.L.-HCV Study Group. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis. 2012;206:469-477.
12. Uto H, Stuver SO, Hayashi K, et al. Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study. Hepatology. 2009;50:393-399.
13. Omland LH, Christensen PB, Krarup H, et al; DANVIR Cohort Study. Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study. PLoS One. 2011;6:e22476.
14. Hansen AB, Lohse N, Gerstoft J, et al. Cause-specifc excess mortality in siblings of patients co-infected with HIV and hepatitis C virus. PLoS One. 2007;2:e738.
15. Tassiopoulos K, Bernstein J, Heeren T, Levenson S, Hingson R, Bernstein E. Hair testing and self-report of cocaine use by heroin users. Addiction. 2004;99:590-597.
16. O'Brien SF, Xi G, Yi QL, Goldman M. Understanding non-disclosure of deferrable risk: a study of blood donors with a history of intravenous drug use. Transfus Med. 2010;20:15-21.
17. Last JM. A Dictionary of Epidemiology, 4th ed. New York: Oxford University Press; 2001.
18. Perez CM, Suarez E, Torres EA, Roman K, Colon V. Seroprevalence of hepatitis C virus and associated risk behaviours: a population-based study in San Juan, Puerto Rico. Int J Epidemiol. 2005;34: 593-599.
19. Dalgard O, Jeansson S, Skaug K, Raknerud N, Bell H. Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol. 2003;38:864-870.
20. Armstrong GL, Wasley A, Simard E P, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705-714.
21. Alter MJ, Kruszon-Moran D, Nainan O V, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556-562.
22. Meffre C, Le SY, Delarocque-Astagneau E, et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol. 2010;82:546-555.
23. Rothman KJ. Biases in Study Design. In: Epidemiology - An Introduction, 1st ed. Rothman KJ, editor. New York: Oxford University Press; 2002:94-112.
24. Lewis CE, Smith E, Kercher C, Spitznagel E. Predictors of mortality in alcoholic men: a 20-year follow-up study. Alcohol Clin Exp Res. 1995; 19:984-991.
25. Dalton SO, Steding-Jessen M, Gislum M, Frederiksen K, Engholm G, Schuz J. Social inequality and incidence of and survival from cancer in a population-based study in Denmark, 1994-2003: Background, aims, material and methods. Eur J Cancer. 2008;44:1938-1949.
26. Romelsjo A, Diderichsen F. Changes in alcohol-related inpatient care in Stockholm County in relation to socioeconomic status during a period of decline in alcohol consumption. Am J Public Health. 1989;79: 52-56.
27. De Campos Lopes CB, Yamada AT, Araujo F, Pereira Barreto AC, Mansur AJ. Socioeconomic factors in the prognosis of heart failure in a Brazilian cohort. Int J Cardiol. 2006;113:181-187.
28. Hemingway H, Marmot M. Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ. 1999;318: 1460-1467.
29. Kunst AE, del RM, Groenhof F, Mackenbach J P. Socioeconomic inequalities in stroke mortality among middle-aged men: an international overview. European Union Working Group on Socioeconomic Inequalities in Health. Stroke. 1998;29:2285-2291.
30. Mookadam F, Arthur HM. Social support and its relationship to morbidity and mortality after acute myocardial infarction: systematic overview. Arch Intern Med. 2004;164:1514-1518.
31. Jepsen P, Vilstrup H, Andersen PK, Sorensen HT. Socioeconomic status and survival of cirrhosis patients: a Danish nationwide cohort study. BMC Gastroenterol. 2009;9:35.
32. Statistics Denmark. Population and election. Population and population forecasts. Population at the first day of the quarter by municipality, sex, age, marital status, ancestry, country of origin and citizenship (FOLK1). Available from: http://www.statbank.dk/statbank5a/default. asp?w=1280. Accessed March 20, 2013.
33. Christensen PB, Hay G, Jepsen P, et al. Hepatitis C prevalence in Denmark - an estimate based on multiple national registers. BMC Infect Dis. 2012;12:178.
34. Hansen N, Obel N, Christensen PB, et al; Danish Database for Hepatitis B and C (DANHEP) group. Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort study. BMC Infect Dis. 2011;11:177.
35. Statistics Denmark. Labour, earnings and income. Unemployment. Unemployed persons in per cent of the labour force by region, age and sex (AUP02). Available from: http://www.statbank.dk/statbank5a/ default.asp?w=1280. Accessed March 20, 2013.
36. The Central Office of Civil Registration. Available from: http://www. cpr.dk/cpr/site.aspx?p=34. Accessed March 20, 2013.
37. Krarup HB, Drewes AM, Madsen PH. A quantitative HCV-PCR test for routine diagnostics. Scand J Clin Lab Invest. 1998;58: 415-422.
38. Omland LH, Jepsen P, Skinhoj P, et al. The impact of HIV-1 co-infection on long-term mortality in patients with hepatitis C: a population-based cohort study. HIV Med. 2009;10:65-71.
39. Statistics Denmark. The Integrated Database for Labour Market Research. Available from: http://www.dst.dk/en/Statistik/dokumen tation/Declarations/integrated-database-for-labour-market-research--ida-.aspx. Accessed March 20, 2013.
40. Statistics Denmark. SOCIO02 (high quality documentation). Available from: http://www.dst.dk/da/TilSalg/Forskningsservice/ Dokumentation/ hoejkvalitetsvariable/personers-tilknytning-til-arbejdsmarkedet-set-over-hele-aaret--akm-/socio02.aspx. Accessed March 20, 2013. Danish.
41. Statistics Denmark. SOCIO (high quality documentation). Avaiable from: http://www.dst.dk/da/TilSalg/Forskningsservice/Dokumenta-tion/hoejkvalitetsvariable/personers-tilknytning-til-arbejdsmarkedet-set-over-hele-aaret--akm-/socio.aspx. Accessed March 20, 2013. Danish.
42. Statistics Denmark. The Attainment Register. Available from: http:// www.dst.dk/en/Statistik/dokumentation/Declarations/the-attainment-register.aspx. Accessed March 20, 2013.
43. The National Board of Health. Klassifkation af sygdomme [Classif-cation of diseases]: 8th revision. Denmark: Sundhedsstyrelsen; 1986. Danish.
44. The National Board of Health. Klassifkation af sygdomme [Classifca-tion of diseases]: 10th revision. Denmark: Sundhedsstyrelsen; 1993. Danish.
45. Statens Serum Institut. The National Patient Registry (Landspa-tientregistret). Available from: http://www.ssi.dk/Sundhedsdataogit/ Registre/Landspatientregisteret.aspx. Accessed March 20, 2013. Danish.
46. Statens Serum Institut. The Registry of Drug Abusers Undergoing Treatment (Register over stofmisbrugere I behandling). Available from: http://www.ssi.dk/Sundhedsdataogit/Registre/Register%20over%20 stofmisbrugere%20i%20behandling.aspx. Accessed March 20, 2013. Danish.
47. Szklo M, Nieto FJ. Basic Study Designs in Analytic Epidemiology. In: Epidemiology: Beyond the Basics, 2nd ed. Sudbury: Jones and Bartlett Publishers; 2012:3-42.
48. Pedersen J, Bjorner JB, Burr H, Christensen KB. Transitions between sickness absence, work, unemployment, and disability in Denmark 2004-2008. Scand J Work Environ Health. 2012;38:516-526.
49. Carlsen K, Harling H, Pedersen J, Christensen KB, Osler M. The transition between work, sickness absence and pension in a cohort of Danish colorectal cancer survivors. BMJ Open. 2013;3(2).
50. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
51. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57:1288-1294.
52. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83.
53. Quan H, Sundararajan V, Halfon P et al. Coding algorithms for defning comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130-1139.
54. Clayton D, Hills M. Conditional logistic regression. Statistical Models in Epidemiology, 1st ed. New York: Oxford University Press Inc; 1993:290-297.
55. The National Board of Health. Guide to the prevention of viral hepatitis. Available from: http://www.sst.dk/publ/Publ2002/hepatitis/html/index.htm. Accessed Mar 20, 2013. Danish.
56. The National Board of Health. Narkosituationen i Danmark 2010. Available from: http://www.sst.dk/publ/Publ2010/CFF/Narkotika/ NarkotikasituationenDK2010.pdf. Accessed Mar 20, 2013. Danish.
57. Ly KN, Xing J, Klevens RM, Jiles RB, Ward J W, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156:271-278.
58. Verna EC, Valadao R, Farrand E, et al. Effects of ethnicity and socio-economic status on survival and severity of fbrosis in liver transplant recipients with hepatitis C virus. Liver Transpl. 2012;18:461-467.
59. Skalicka V, van LF, Bambra C, Krokstad S, Mackenbach J. Material, psychosocial, behavioural and biomedical factors in the explanation of relative socio-economic inequalities in mortality: evidence from the HUNT study. Int J Epidemiol. 2009;38:1272-1284.
60. Lettmeier B, Muhlberger N, Schwarzer R, et al. Market uptake of new antiviral drugs for the treatment of hepatitis C. J Hepatol. 2008;49: 528-536.